Pregabalin Orally Disintegrating Tablets 150 mg (Pregabalin)

Adult dosage

This medication is pregabalin and is to be taken orally divided into two doses daily regardless of food. Place on the tongue to allow it to dissolve and swallow without water. 1. Neuropathic Pain - Peripheral Neuropathic Pain: Starting dose 150 mg daily, can be increased to 300 mg daily after 3-7 days, and if necessary increased to a maximum of 600 mg daily at intervals of 7 days. - Central Neuropathic Pain:

Children's dosage

Safety and effectiveness have not been established in children under 12 years of age and adolescents aged 12-17 years, so administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors; if mood changes or unusual behaviors occur during treatment, it is crucial to inform healthcare professionals immediately. This medication should not be used if there is a history of allergic reactions to it or its components. Diabetic patients may need to adjust their blood sugar control medications due to weight gain from taking this medication, so caution is advised. If swelling occurs in the face or around the mouth, discontinue use immediately and consult a healthcare professional. Elderly patients are at risk of dizziness and drowsiness, increasing the risk of falls, so caution is required, especially at the beginning of treatment. Visual disturbances or changes in eyesight can occur, so these symptoms should be reported to healthcare professionals. Abrupt cessation of this medication can lead to withdrawal symptoms such as insomnia, headache, and anxiety, so it should be tapered off under medical supervision. Due to the risk of drug abuse, patients with a history of substance abuse should exercise special caution when taking this medication. Patients with impaired kidney function may require dosage adjustments. Patients with cardiac diseases should use this medication cautiously due to the risk of congestive heart failure. There is a central nervous system depressant effect, which can lead to drowsiness, stupor, and respiratory depression; therefore, caution is necessary when used in combination with opioids or similar medications. During early pregnancy, there is a risk of fetal malformations, so pregnant women should avoid taking this medication, and women of childbearing age should use effective contraception during treatment. Breastfeeding women should discuss with their healthcare provider regarding the continuation of breastfeeding or the discontinuation of this medication, as it can be transmitted through breast milk. It is advisable to avoid hazardous activities such as driving or operating machinery until dizziness or drowsiness resolves after taking this medication. If severe skin reactions such as rashes, fever, or mucosal damage occur during treatment, discontinue use immediately and inform healthcare professionals. Overdosage may result in symptoms like confusion, drowsiness, and depression; seek emergency treatment if suspected. Keep this medication out of reach of children, and avoid transferring it to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, peeling of the skin, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by coughing and fever, yellowing of skin or eyes (jaundice), profound malaise, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urination issues

Mild side effects

• Dizziness
• drowsiness
• confusion
• impaired spatial orientation
• irritability
• depression
• feelings of euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. The recommended storage temperature is between 1°C and 30°C at room temperature.

Appearance

Pink oval orally disintegrating tablet

Package unit

30 tablets/PTP [10 tablets/PTP x 3], 100 tablets/PTP [10 tablets/PTP x 10]